Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
CYAD - Celyad Oncology SA
Market Cap 14.24M P/E - EPS this Y - Ern Qtrly Grth -
Income -40.94M Forward P/E -0.11 EPS next Y - 50D Avg Chg -34.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -59.00%
Dividend N/A Price/Book 2.46 EPS next 5Y - 52W High Chg -85.00%
Recommedations 3.00 Quick Ratio 1.31 Shares Outstanding 22.59M 52W Low Chg 213.00%
Insider Own 0.05% ROA -25.41% Shares Float 13.58M Beta 1.69
Inst Own 29.16% ROE -170.72% Shares Shorted/Prior 130.17K/151.27K Price 0.47
Gross Margin - Profit Margin - Avg. Volume 18,160 Target Price 8.52
Oper. Margin - Earnings Date - Volume 48,998 Change -12.96%
Healthcare | Biotechnology | Belgium
About Celyad Oncology SA

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

CYAD Chatroom

User Image Rkytect Posted - 04/15/24

$CYAD lets

User Image Stock_Titan Posted - 04/04/24

$CYAD Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights https://www.stocktitan.net/news/CYAD/celyad-oncology-reports-full-year-2023-financial-results-and-recent-qgf5f8zszwgn.html

User Image theParkingDiva Posted - 02/22/24

$CYAD 🤔

User Image Stock_Titan Posted - 02/08/24

$CYAD Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations https://www.stocktitan.net/news/CYAD/celyad-oncology-announces-intention-to-terminate-sec-reporting-q2qs46bhatzs.html

User Image cctranscripts Posted - 01/17/24

Celyad: A Robust And Broad Intellectual Property (Ip) Portfolio Mont-Saint-Guibert, Belgium, Ja https://www.conferencecalltranscripts.org/summary/?id=12871346 $CYAD

User Image cctranscripts Posted - 12/21/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12812922 $CYAD

User Image Stock_Titan Posted - 12/20/23

$CYAD Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC https://www.stocktitan.net/news/CYAD/celyad-oncology-sa-publication-of-a-transparency-notification-s6onralf6exq.html

User Image cctranscripts Posted - 12/18/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12800534 $CYAD

User Image Stock_Titan Posted - 12/15/23

$CYAD Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) https://www.stocktitan.net/news/CYAD/celyad-oncology-information-on-the-total-number-of-voting-rights-and-zi92imeigomc.html

User Image cctranscripts Posted - 12/04/23

Celyad Oncology Forward-Looking Statement https://www.conferencecalltranscripts.org/summary/?id=12761485 $CYAD

User Image cctranscripts Posted - 12/04/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12761483 $CYAD

User Image cctranscripts Posted - 11/24/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12737129 $CYAD

User Image EarningsInsider Posted - 11/24/23

Celyad Oncology SA Files SEC Form 6-K $CYAD https://www.marketbeat.com/stocks/NASDAQ/CYAD/sec-filings/

User Image EarningsInsider Posted - 11/21/23

Celyad Oncology SA Files SEC Form 6-K $CYAD https://www.marketbeat.com/stocks/NASDAQ/CYAD/sec-filings/

User Image Stock_Titan Posted - 11/21/23

$CYAD Celyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLC https://www.stocktitan.net/news/CYAD/celyad-oncology-sa-publication-of-a-transparency-notification-p57lvzo0j120.html

User Image cctranscripts Posted - 11/21/23

Celyad: Rue André Dumont, 9 https://www.conferencecalltranscripts.org/summary/?id=12726887 $CYAD

User Image EarningsInsider Posted - 11/21/23

Celyad Oncology SA Files SEC Form 6-K $CYAD https://www.marketbeat.com/stocks/NASDAQ/CYAD/sec-filings/

User Image cctranscripts Posted - 11/15/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12712348 $CYAD

User Image EarningsInsider Posted - 11/15/23

Celyad Oncology SA Files SEC Form 6-K $CYAD https://www.marketbeat.com/stocks/NASDAQ/CYAD/sec-filings/

User Image Stock_Titan Posted - 11/09/23

$CYAD Celyad Oncology reports third quarter 2023 financial results and recent business highlights https://www.stocktitan.net/news/CYAD/celyad-oncology-reports-third-quarter-2023-financial-results-and-9uc1dv9fvqsd.html

User Image cctranscripts Posted - 09/26/23

Celyad: Press Release – Regulated Information CELYAD ONCOLOGY ANNOUNCES THE TERMINATION OF ITS https://www.conferencecalltranscripts.org/summary/?id=12566485 $CYAD

User Image Quantisnow Posted - 09/26/23

$CYAD 📜 SEC Form 6-K filed by Celyad Oncology SA https://quantisnow.com/i/4987162?utm_source=stocktwits 45 seconds delayed.

User Image Stock_Titan Posted - 09/25/23

$CYAD Celyad Oncology Announces the Termination of Its American Depository Receipt Program https://www.stocktitan.net/news/CYAD/celyad-oncology-announces-the-termination-of-its-american-depository-bvez6ddsoavu.html

User Image cctranscripts Posted - 09/22/23

Celyad: Rue Edouard Belin, 2 https://www.conferencecalltranscripts.org/summary/?id=12559754 $CYAD

User Image cctranscripts Posted - 09/18/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12545780 $CYAD

User Image Stonkmoon Posted - 09/15/23

$CYAD 2023-09-15 16:01 ET Celyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC https://stonkmoon.com/news/CYAD/93ad8b30c5810c39c9ee87c5c53a91d4

User Image Stock_Titan Posted - 09/15/23

$CYAD Celyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC https://www.stocktitan.net/news/CYAD/celyad-oncology-sa-publication-of-a-rectified-transparency-9jxidfjox9id.html

User Image cctranscripts Posted - 09/13/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12535475 $CYAD

User Image Stock_Titan Posted - 09/12/23

$CYAD Celyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SA https://www.stocktitan.net/news/CYAD/celyad-oncology-sa-publication-of-a-transparency-notification-zuntal8w2lu4.html

User Image cctranscripts Posted - 09/11/23

Celyad: Press Release - Regulated Information https://www.conferencecalltranscripts.org/summary/?id=12528930 $CYAD

Analyst Ratings
Wells Fargo Overweight Jan 11, 22
HC Wainwright & Co. Buy Aug 6, 21
HC Wainwright & Co. Buy May 10, 21
JonesTrading Hold Mar 26, 21
HC Wainwright & Co. Buy Dec 8, 20
Wells Fargo Overweight Mar 26, 20
H.C. Wainwright Buy Mar 25, 20
H.C. Wainwright Buy Jul 2, 18
SunTrust Robinson Humphrey Buy May 31, 18